Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis

Kidney360. 2020 Dec 1;2(3):477-486. doi: 10.34067/KID.0005612020. eCollection 2021 Mar 25.

Abstract

Background: The development of glomerulosclerosis in FSGS is associated with a reduction in podocyte number in the glomerular capillary tufts. Although it has been reported that the number of urinary podocytes in FSGS exceeds that of minimal-change nephrotic syndrome, the nature of events that promote podocyte detachment in FSGS remains elusive.

Methods: In this study, we provide detailed, morphologic analysis of the urinary podocytes found in FSGS by examining the size of the urinary podocytes from patients with FSGS, minimal-change nephrotic syndrome, and GN. In addition, in urinary podocytes from patients with FSGS and minimal-change nephrotic syndrome, we analyzed podocyte hypertrophy and mitotic catastrophe using immunostaining of p21 and phospho-ribosomal protein S6.

Results: The size of the urinary podocytes was strikingly larger in samples obtained from patients with FSGS compared with those with minimal-change nephrotic syndrome and GN (P=0.008). Urinary podocytes from patients with FSGS had a higher frequency of positive immunostaining for p21 (P<0.001) and phospho-ribosomal protein S6 (P=0.02) than those from patients with minimal-change nephrotic syndrome. Characteristic features of mitotic catastrophe were more commonly observed in FSGS than in minimal-change nephrotic syndrome urinary samples (P=0.001).

Conclusions: We posit that the significant increase in the size of urinary podocytes in FSGS, compared with those in minimal-change nephrotic syndrome, may be explained by hypertrophy and mitotic catastrophe.

Keywords: focal segmental glomerulosclerosis; glomerular and tubulointerstitial diseases; hypertrophy; minimal change nephrotic syndrome; mitotic catastrophe; p21; podocyte.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glomerulosclerosis, Focal Segmental* / metabolism
  • Humans
  • Kidney Diseases* / metabolism
  • Nephrosis, Lipoid* / metabolism
  • Podocytes* / metabolism